Page last updated: 2024-08-21

cyclopentane and olaparib

cyclopentane has been researched along with olaparib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, ZP; Hu, YC; Jin, F; Liu, XD; Ma, T; Song, ZQ; Xie, Y; Zhou, PK1

Other Studies

1 other study(ies) available for cyclopentane and olaparib

ArticleYear
MLN4924 suppresses the BRCA1 complex and synergizes with PARP inhibition in NSCLC cells.
    Biochemical and biophysical research communications, 2017, 01-29, Volume: 483, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Line, Tumor; Cyclopentanes; DNA Damage; DNA-Binding Proteins; Histone Chaperones; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Multiprotein Complexes; NEDD8 Protein; Nuclear Proteins; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Pyrimidines; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitins

2017